Service | Source | Final Application Due Date | Funding Available | Match Required |
---|---|---|---|---|
Health Care |
Federal
HHS |
01-31-2025 | N/A | No Match Required |
93.083 -- Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases
93.084 -- Prevention of Disease, Disability, and Death by Infectious Diseases
93.113 -- Environmental Health
93.121 -- Oral Diseases and Disorders Research
93.143 -- NIEHS Superfund Hazardous Substances_Basic Research and Education
93.172 -- Human Genome Research
93.173 -- Research Related to Deafness and Communication Disorders
93.213 -- Research and Training in Complementary and Integrative Health
93.233 -- National Center on Sleep Disorders Research
93.242 -- Mental Health Research Grants
93.262 -- Occupational Safety and Health Program
93.273 -- Alcohol Research Programs
93.279 -- Drug Abuse and Addiction Research Programs
93.307 -- Minority Health and Health Disparities Research
93.350 -- National Center for Advancing Translational Sciences
93.351 -- Research Infrastructure Programs
93.394 -- Cancer Detection and Diagnosis Research
93.395 -- Cancer Treatment Research
93.837 -- Cardiovascular Diseases Research
93.838 -- Lung Diseases Research
93.839 -- Blood Diseases and Resources Research
93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research
93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
93.855 -- Allergy and Infectious Diseases Research
93.859 -- Biomedical Research and Research Training
93.865 -- Child Health and Human Development Extramural Research
93.866 -- Aging Research
93.867 -- Vision Research
Through this I-Corps at NIH program Notice of Funding Opportunity (NOFO), NIH and CDC provide administrative supplement awards to active SBIR (NIH and CDC) and STTR Phase I (NIH only) grantees/awardees. The I-Corps at NIH mission is to empower entrepreneurs in developing and validating a strategic business model through diverse customer discovery in order to meet unmet clinical needs. I-Corps enables and accelerates the transformation of invention to impact SBIR and STTR Phase I awardees in a no-cost extension are eligible as long as, if selected, their no cost extension covers the entire duration of I-Corps at NIH cohort. The program provides three-member project teams with access to instruction and mentoring to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact Scientific/Research staff for more information about the program before applying.
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See funding announcement for eligibility details
NIH Grants Information
grantsinfo@nih.gov
How would you rate your overall experience on our website?
How easy is it to find the information you need?
How do you rate the look & feel of our website?
How could we improve our website?